肾臟病学和泌尿系统市场报告：2030 年趋势、预测和竞争分析

肾臟病学和泌尿系统的趋势和预测

全球肾臟病学和泌尿系统市场的未来看起来充满希望，医院、诊所和门诊手术中心市场充满机会。预计到 2030 年，全球肾臟病和泌尿系统市场将达到 97 亿美元，2024 年至 2030 年复合年增长率为 6.6%。该市场的主要驱动因素是慢性病盛行率的上升、透析患者数量的增加以及对微创 (MI) 设备的日益偏好。

• 在产品类型中，Lucintel预测经皮肾造口导管将在预测期内大量使用，因为经皮肾造口导管主要用于治疗肾移植问题、肾臟或肾週储存减压以及非扩张性闭塞治疗。
• 在最终用途类别中，由于肾臟病患者住院人数的增加、先进治疗设备的随时可用以及在医疗机构接受透析的患者的增加，医院可能仍然是最大的部分。
• 从地区来看，由于肾臟病患者数量不断增加、熟练医生的存在以及成熟的医疗设施的存在，预计北美在预测期内将出现最高的增长。

肾臟科和泌尿系统市场的策略性成长机会

各种应用和其他因素创造了该领域的策略成长机会。

• 扩大远端医疗：扩大远距远端医疗服务是重要途径，不仅可以加强病患管理，还可以改善获得照护的机会。必须开发强大的远端医疗平台，以缩小服务不足人口的服务差距。
• 机器人手术系统：成为机器人手术系统的投资者提供了成长的机会，因为它提供了尖端的手术解决方案。在临床环境中，它提高了泌尿系统手术的准确性和结果。
• 人工肾臟技术的进步为透析市场带来了成长机会。这意味着旨在使慢性肾臟病管理更加有效和方便的创新可以解决这一未满足的需求。
• 个人化治疗解决方案：在肾臟病学和泌尿系统领域，这种利用患者资料的个人化医疗方法具有推动成长的潜力。因此，这些进展预计将改善治疗结果和患者满意度。
• 诊断工具的创新：透过增加可用诊断工具的种类可以改善肾臟和泌尿系统疾病的早期检测和监测。因此，诊断成像和生物标记测试的进步将提高诊断准确性。

此类机会透过推动创新和改善患者照护来塑造肾臟病学和泌尿系统市场。

肾臟病学和泌尿系统市场的驱动因素和挑战

肾臟病和泌尿系统市场受到各种驱动因素​​的影响，这也是影响其成长和市场发展的主要挑战。

肾臟科和泌尿系统市场的驱动因素包括：

• 技术进步：创新诊断工具、手术技术和数位健康解决方案的使用将推动该细分市场的成长。这些改进将提高肾科护理的整体效率和有效性，特别是对于泌尿系统而言。
• 肾臟和泌尿系统疾病的发生率不断增加：肾臟和泌尿系统疾病的盛行率不断增加，导致需要更复杂的治疗方案。这一趋势正在推动新技术和治疗方法的开发和传播。
• 更加关注个人化医疗：向个人化医疗的转变正在透过根据患者个体情况量身定制医疗方案来改善治疗结果。这种方法不仅在泌尿系统而且在肾臟病学中得到认可。
• 远端医疗服务的扩展：远端医疗服务的成长正在增加获得治疗的机会并改善病患管理。肾臟内科、泌尿系统的治疗开始采用远距会诊和监护。
• 增加研发投资：这笔资金将透过研发投资促进肾臟科和泌尿系统技术的进步。我们特别支持新治疗方法和诊断工具的开发。

肾臟病学和泌尿系统市场面临的挑战如下：

• 先进技术的高成本：先进技术设备的高成本可能成为其采用的障碍。医疗保健提供者和患者面临着平衡成本和可近性的挑战。
• 监管和合规问题：在确保满足标准的同时就一系列监管要求进行谈判可能会出现问题。它影响市场准入和新产品批准等问题。
• 资料隐私问题：确保病患资料的安全和隐私是一项重大挑战。遵守资料保护规则和满足患者需求对于维持信任至关重要。

肾臟病学和泌尿系统市场是由这些影响创新、采购决策和监管要求的驱动因素和挑战所塑造的。

目录

第一章执行摘要

第二章全球肾臟病学和泌尿系统市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球肾臟病学和泌尿系统市场趋势（2018-2023）和预测（2024-2030）
• 全球肾臟病学和泌尿系统市场：副产品
  • 输尿管导管
  • PCN导管
  • 输尿管支架
  • 石篮
  • 泌尿系统导管导引线
  • 肾扩张器
  • 其他的
• 全球肾臟病学和泌尿系统市场：按应用分类
  • 尿道结石
  • 泌尿系统癌症及良性前列腺增生
  • 膀胱疾病
  • 肾臟疾病
  • 其他的
• 全球肾病学和泌尿系统市场：按最终用途行业
  • 医院
  • 诊所
  • 门诊手术中心
  • 其他的

第四章 2018-2030年区域市场趋势及预测分析

• 按地区分類的全球肾臟病学和泌尿系统市场
• 北美肾臟病学/泌尿系统市场
• 欧洲肾臟病学和泌尿系统市场
• 亚太肾臟病学和泌尿系统市场
• 其他地区肾臟病、泌尿系统市场

第五章 竞争分析

• 产品系列分析
• 业务整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球肾臟病学和泌尿系统市场成长机会（按产品）
  • 全球肾臟病学和泌尿系统市场应用的成长机会
  • 最终用途产业的全球肾臟病学和泌尿系统市场成长机会
  • 全球肾臟病学和泌尿系统市场区域成长机会
• 全球肾臟病学和泌尿系统市场新趋势
• 战略分析
  • 新产品开发
  • 扩大全球肾臟科和泌尿系统市场的产能
  • 全球肾臟病学和泌尿系统市场的合併、收购和合资企业
  • 认证和许可

第七章主要企业概况

• Medtronic
• Coloplast
• Boston Scientific
• ConvaTec
• B. Braun
• Hollister
• Teleflex
• Baxter
• Fresenius Medical Care
• Asahi Kasei

Nephrology and Urology Trends and Forecast

The future of the global nephrology and urology market looks promising with opportunities in the hospital, clinic, and ambulatory surgical center markets. The global nephrology and urology market is expected to reach an estimated $9.7 billion by 2030 with a CAGR of 6.6% from 2024 to 2030. The major drivers for this market are the rising prevalence of chronic diseases, the increasing number of dialysis patients, and the growing preference for minimally invasive (MI) devices.

• Lucintel forecast that, within the product category, the percutaneous nephrostomy catheter is expected to witness the highest growth over the forecast period due to its significant use in treating problems from kidney transplants, decompressing nephric or perinephric fluid collection, and non-dilated obstructive therapies.
• Within the end-use category, hospitals will remain the largest segment due to the increasing admission of renal disease patients, easy availability of advanced treatment devices, and the growing number of patients obtaining dialysis in medical facilities.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to the growing number of kidney-affected patients, the presence of skilled physicians, and the availability of well-established healthcare facilities in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Nephrology and Urology Market

Emerging trends in the nephrology and urology market have a bearing on future care given advances in technology as well as changing patient needs.

• Integration of Artificial Intelligence: AI is progressively finding its way into diagnostic systems as well as treatment options available for nephrologists and urologists. AI algorithms are essential in improving diagnostics' accuracy, personalizing treatment plans, as well as enhancing predictive analytics thereby leading to improved patient outcomes.
• Advancements in Minimally Invasive Surgery: The use of minimally invasive techniques such as laparoscopic surgery and robot-assisted surgery has been gaining popularity among surgeons. These approaches minimize complications, hasten recovery, and offer more accurate treatments thus benefiting patients.
• Expansion of Telehealth Services: Telehealth technology is now being used more often by nephrologists and urologists allowing them to provide consultations remotely or monitor their patients over time. This trend makes it easier for all people regardless of their place of living to access healthcare services also simplifying the management of chronic conditions.
• Focus on Personalized Medicine: Personalized medicine is catching on with treatments that fit individual genetic formulae and target specific health conditions. This model intends to maximize therapeutic effectiveness while minimizing side effects by customizing care using patient-specific data.
• Development of Advanced Diagnostic Tools: Improved imaging techniques and biomarker-based tests are being witnessed in the field of diagnostics. These developments enable early detection and more accurate diagnosis of urology and kidney-related ailments.

These trends enhance diagnostic precision, treatment efficiency, and patient reachability; consequently reshaping the nephrology & urology market.

Recent Developments in the Nephrology and Urology Market

Advancements in technology and new treatment methods characterize the recent important developments in the nephrology and urology market.

• Artificial Kidney Technologies: The artificial kidney technologies under development aim at improving dialysis efficiency as well as patients' comfort during therapy procedures. They mainly focus on designing wearable or implantable devices that mimic kidney functions better than ever before.
• Robotic-Assisted Surgeries: Robotic-assisted surgery systems have been introduced into urological practice which has led to a revolution in urological operations. These assistive machines provide a higher level of precision and control, thus reducing complications while also speeding up recovery time.
• Telehealth Integration: Telehealth's growth has improved the management of nephrology and urology at a distance. It is leading to greater patient involvement and increased availability through virtual consultations and remote monitoring tools.
• Advanced Imaging Techniques: Modern imaging techniques, such as high-resolution MRI, and 3D ultrasound are improving diagnosis accuracy and treatment planning for renal and urological diseases.
• Personalized Medicine Approaches: Personalized medicine has been taken up which facilitates individualized therapy based on patient profiles, leading to better outcomes in treatment while minimizing side effects.

These developments are driving innovation and improving the quality of care in nephrology and urology.

Strategic Growth Opportunities for Nephrology and Urology Market

Various applications among others have led to strategic growth opportunities emerging in this field.

• Telemedicine Expansion: A significant avenue for expansion of telemedicine services is offered by increasing care access as well as enhancing patient management. To bridge service gaps reaching underserved populations; robust telehealth platforms should be developed.
• Robotic Surgery Systems: Becoming an investor in robotic surgery systems brings about chances for growth as it provides state-of-the-art surgical solutions. In clinical settings, these systems promote precision and outcomes during urological surgeries.
• Advances in artificial kidney technologies can lead to growth opportunities in the dialysis market. This, therefore, means that innovations aimed at making chronic kidney disease management more effective and convenient would be able to address this unmet need.
• Personalized Treatment Solutions: Growth can result from personalized medicine approaches that utilize such patient data in the field of nephrology and urology. As a result, these developments are expected to improve therapeutic outcomes and satisfaction levels among patients.
• Innovations in Diagnostic Tools: Early detection and monitoring of kidney and urological diseases may be improved through expanding the variety of diagnostic tools available. Consequently, advances in imaging as well as biomarker testing are poised to increase diagnostic accuracy.

These opportunities are shaping the Nephrology and Urology market by driving innovation and improving patient care.

Nephrology and Urology Market Driver and Challenges

The nephrology and urology market is influenced by various drivers, which are also major challenges that affect its growth as well as development.

The factors responsible for driving the nephrology and urology market include:

• Technological Advancements: The use of innovative diagnostic tools, surgical techniques, and digital health solutions drives the increase of this market segment. These improvements lift efficiency as well as effectiveness throughout nephrology care especially when it comes to urologists.
• Rising Incidence of Kidney and Urological Disorders: The increasing prevalence of renal and urogenital conditions is leading to the need for more sophisticated treatment options. This trend pushes forward the development and uptake of new technologies and therapies.
• Growing Focus on Personalized Medicine: A shift toward personalized healthcare has increased successful treatment outcomes by adjusting medical regimens to suit individual patient profiles. Such a method is being recognized in nephrology as well as urology.
• Expansion of Telehealth Services: The increasing growth in telehealth services is enhancing access to care and improving patient management. Nephrology and urology care are beginning to incorporate remote consultation and monitoring.
• Increased Research and Development Investment: This funding promotes the advancement of nephrology as well as urology technologies through investment in research and development. It supports the creation of fresh therapeutic methods and diagnostic tools among other things.

Challenges in the nephrology and urology market are:

• High Costs of Advanced Technologies: High prices for advanced technological devices can act as an obstacle to their adoption. Healthcare providers together with patients face a challenge in striking a balance between cost and accessibility.
• Regulatory and Compliance Issues: Negotiating labyrinthine regulatory requirements while ensuring standards are met can be problematical. They affect issues like entry into the market or clearance for novel products.
• Data Privacy Fears: It is a big task to ensure that patient data security and privacy are observed. To maintain trust, compliance with the rules of data protection and responding to patients' needs are essential.

The nephrology and urology market is being shaped by these driving forces and challenges by affecting innovation, purchase decisions as well as regulatory requirements.

List of Nephrology and Urology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies nephrology and urology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nephrology and urology companies profiled in this report include-

• Medtronic
• Coloplast
• Boston Scientific
• ConvaTec
• B. Braun
• Hollister
• Teleflex
• Baxter
• Fresenius Medical Care
• Asahi Kasei

Nephrology and Urology by Segment

The study includes a forecast for the global nephrology and urology by product, application, end use industry, technology, and region

Nephrology and Urology Market by Product [Analysis by Value from 2018 to 2030]:

• Ureteral Catheters
• PCN Catheters
• Urinary Stents
• Stone Basket
• Urology Guidewires
• Renal Dilators

Nephrology and Urology Market by Application [Analysis by Value from 2018 to 2030]:

• Urolithiasis
• Urological Cancer & BPH
• Bladder Disorders
• Kidney Diseases
• Others

Nephrology and Urology Market by End Use Industry [Analysis by Value from 2018 to 2030]:

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

Nephrology and Urology Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Nephrology and Urology Market

The latest trends in the nephrology and urology market show innovative treatment technologies and a growing global attention to patient-centered care.

• United States: The United States has witnessed significant milestones towards managing kidney diseases including the use of artificial kidneys and improved dialysis techniques. There is also an increasing trend for personalized medical care as well as telehealth solutions meant to enhance patients' outcomes in nephrology and urology.
• China: Technological advancements in China have led to the rapid development of advanced diagnostic tools alongside minimal invasive surgical approaches. These include imaging innovations as well as robotic-assisted surgeries that are increasingly used to improve the efficiency of care processes and reduce recovery periods for patients with nephrological or urological conditions.
• Germany: Germany is leading in digital health integration into nephrology and urology care. Most recently, there have been developments such as advanced telemedicine platforms and electronic health records for adequate management of chronic kidney diseases plus complex urological procedures support.
• India: In India, however, there has been a focus on expanding access to nephrology/urology through affordable options & creation of specialized centers. Consequently, new technologies are being developed while existing ones are being refined so that they can be able to cope with the increasing number of renal disorders & urogenital abnormalities.
• Japan: Japan is at the forefront of developing high-precision diagnostic tools and treatment technologies for nephrology and urology. Recent milestones include state-of-the-art imaging methods and robots with surgical precision that facilitate better results for patients.

Features of the Global Nephrology and Urology Market

Market Size Estimates: Nephrology and urology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Nephrology and urology market size by product, application, end use industry, and region in terms of value ($B).

Regional Analysis: Nephrology and urology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, applications, end use industries, and regions for the nephrology and urology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nephrology and urology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the nephrology and urology market by product (ureteral catheters, PCN catheters, urinary stents, stone basket, urology guidewires, renal dilators, and others), application (urolithiasis, urological cancer & BPH, bladder disorders, kidney diseases, and others), end use industry (hospitals, clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Nephrology and Urology Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Nephrology and Urology Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Nephrology and Urology Market by Product
  • 3.3.1: Ureteral Catheters
  • 3.3.2: PCN Catheters
  • 3.3.3: Urinary Stents
  • 3.3.4: Stone Basket
  • 3.3.5: Urology Guidewires
  • 3.3.6: Renal Dilators
  • 3.3.7: Others
• 3.4: Global Nephrology and Urology Market by Application
  • 3.4.1: Urolithiasis
  • 3.4.2: Urological Cancer & BPH
  • 3.4.3: Bladder Disorders
  • 3.4.4: Kidney Diseases
  • 3.4.5: Others
• 3.5: Global Nephrology and Urology Market by End Use Industry
  • 3.5.1: Hospitals
  • 3.5.2: Clinics
  • 3.5.3: Ambulatory Surgical Centers
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Nephrology and Urology Market by Region
• 4.2: North American Nephrology and Urology Market
  • 4.2.1: North American Nephrology and Urology Market by Product: Ureteral Catheters, PCN Catheters, Urinary Stents, Stone Basket, Urology Guidewires, Renal Dilators, and Others
  • 4.2.2: North American Nephrology and Urology Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, and Others
• 4.3: European Nephrology and Urology Market
  • 4.3.1: European Nephrology and Urology Market by Product: Ureteral Catheters, PCN Catheters, Urinary Stents, Stone Basket, Urology Guidewires, Renal Dilators, and Others
  • 4.3.2: European Nephrology and Urology Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, and Others
• 4.4: APAC Nephrology and Urology Market
  • 4.4.1: APAC Nephrology and Urology Market by Product: Ureteral Catheters, PCN Catheters, Urinary Stents, Stone Basket, Urology Guidewires, Renal Dilators, and Others
  • 4.4.2: APAC Nephrology and Urology Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, and Others
• 4.5: ROW Nephrology and Urology Market
  • 4.5.1: ROW Nephrology and Urology Market by Product: Ureteral Catheters, PCN Catheters, Urinary Stents, Stone Basket, Urology Guidewires, Renal Dilators, and Others
  • 4.5.2: ROW Nephrology and Urology Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Nephrology and Urology Market by Product
  • 6.1.2: Growth Opportunities for the Global Nephrology and Urology Market by Application
  • 6.1.3: Growth Opportunities for the Global Nephrology and Urology Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Nephrology and Urology Market Region
• 6.2: Emerging Trends in the Global Nephrology and Urology Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Nephrology and Urology Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nephrology and Urology Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Medtronic
• 7.2: Coloplast
• 7.3: Boston Scientific
• 7.4: ConvaTec
• 7.5: B. Braun
• 7.6: Hollister
• 7.7: Teleflex
• 7.8: Baxter
• 7.9: Fresenius Medical Care
• 7.10: Asahi Kasei